Oral 1 .alpha.-hydroxyprevitamin D
US5622941A · kind A · utility
35Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 1994 |
| Grant date | Apr 22, 1997 |
| Priority date | — |
| Expiry date | Jan 26, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of increasing activated vitamin D blood level by administering orally a 1.alpha.-hydroxyprevitamin D. This previtamin D form increases vitamin D blood level without significant risk of hypercalcemia associated with other oral dosing of vitamin D forms. The 1.alpha.-hydroxyprevitamin is compounded into a pharmaceutical composition in combination with a pharmaceutically acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.